Cargando…
Trends, geographical variation and factors associated with the use of anti-VEGF intravitreal injections in Portugal (2013–2018): a retrospective analysis of administrative data
AIMS: The arrival of anti-vascular endothelial growth factor (anti-VEGF) therapies represented a treatment shift for several ophthalmological disorders and led to an increasing number of patients undergoing intravitreal injections. The aims of this observational study were to assess the expansion of...
Autores principales: | Rocha, João Victor, Marques, Ana Patricia, Macedo, Antonio Filipe, Afonso-Silva, Marta, Laires, Pedro, Almeida, Ana Sofia, Fernandes, Julieta, Pardal, Marisa, Santana, Rui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987746/ https://www.ncbi.nlm.nih.gov/pubmed/35387817 http://dx.doi.org/10.1136/bmjopen-2021-055478 |
Ejemplares similares
-
Cross-sectional study investigating the prevalence and causes of vision impairment in Northwest Portugal using capture–recapture
por: Ramos, Pedro Lima, et al.
Publicado: (2022) -
Acceptability of intravitreal injections in geographic atrophy: protocol for a mixed-methods pilot study
por: Enoch, Jamie, et al.
Publicado: (2021) -
Comparison of intravitreal dexamethasone implant and anti-VEGF drugs in the treatment of retinal vein occlusion-induced oedema: a meta-analysis and systematic review
por: Ming, Shuai, et al.
Publicado: (2020) -
Intravitreal injections with anti-VEGF agent aflibercept versus subthreshold micropulse laser for chronic central serous chorioretinopathy: the alternative treatment regimens for verteporfin-shortage in China
por: Zhao, Tantai, et al.
Publicado: (2023) -
Intravitreal Anti-vascular Endothelial Growth Factor (Anti-VEGF) Therapy for Valsalva Related Sub-internal Limiting Membrane (Sub-ILM) Macular Haemorrhage: A Case Report
por: Nur-Najwa, Suhaifi, et al.
Publicado: (2023)